Plenary Item 5a Chair: Excellencies, distinguished representatives. Ladies and gentlemen, good morning, I would like to start Agenda Item five, implementation of international drug control treaties. Secretariat: Thank you very much, Mr. Chair, and good morning to all. The commission has before it the Agenda Item 5a: changes in the scope of control of substances. …
Japan
Plenary Item 4. Strategic management, budgetary and administrative questions
UNODC: Mr. Chair, Distinguished delegates, In 2022, UNODC continued to implement its Strategy 2021–2025 during compounding crises related to consequences of the coronavirus disease (COVID-19) pandemic, climate change and the environment, as well as new and protracted conflicts. Progress has been made in turning internal strategies and action plans focusing on enabling efficiencies into actions …
Resolution L4. Safe handling and disposal of synthetic drugs, their precursors and other chemicals used in the illicit manufacture of drugs
Tuesday Morning Session PP3 Russia: “in which it was recognised” – delete “the Commission” – It’s standard practice to quaote the name of the document. Otherwise we might send the wrong signal. US: In compromise “in which Member States recognise” Chair: PP3 Agreed PP4 Chair: No comments? Agreed PP5 Chair: Agreed PP12 Chair: Agreed PP13 …
CND 65th Reconvened Session – 9th December 2022
Reconvened Sixty-fifth session of the Commission on Narcotic Drugs, Vienna, Austria, 8-9 December 2022 Chair: Welcome back. Secretariat: (Reminder on COVID safety measures in Vienna) Agenda item 4. – Strategic management, budgetary and administrative questions Chair: We considered our consolidated budget yesterday. We, as a commission, are now required to take action. There have been …
CND 65th Reconvened Session – 8th December 2022
Reconvened Sixty-fifth session of the Commission on Narcotic Drugs, Vienna, Austria, 8-9 December 2022 CCPCJ Chair: Good Morning. (Opening Statement) >>> CND dates 2023 March 13 – 17 CND Chair: Opening Statement (Agenda adopted) Agenda Item 4. Strategic management, budgetary and administrative questions, including the following sub-items: (a) Work of the standing open-ended intergovernmental working …
CND Chair one-day special forum on availability and access to controlled substances for medical and scientific purposes
Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …